CombiGene and Spark Therapeutics recently held a biannual joint steering committee meeting in Stockholm, Sweden, to

CombiGene is very active at various types of conferences to keep abreast of the rapid scientific

Advanced medicines – often called ATMP (Advanced Therapy Medicinal Products) – such as gene therapy and

At the Annual General Meeting on May 25, 2023, Jonas Ekblom was elected new Chairman of

The pain program COZY, which we are developing together with the Danish company Zyneyro, is currently